CBD /

 

Loading...
Internationally Recognized Certificates of Compliance (IRCC)
  |  
ABSCH-IRCC-IN-207615-1   |   PDF   |   Print   |  
| 
|  Close
last updated: 16 Aug 2016
General Information
India
ABSCH-IRCC-IN-207615-1
Error loading details for ({"identifier":"FBC414FB-2703-FAA5-D553-890A6F9FACNA@1"})
Details of the permit or its equivalent
India/NBA/Appl/9/833

Application in Form-III for seeking approval for the invention “ Method of preparation of herbal extract for cancer treatment” for obtaining IP Rights in India 

17 Dec 2015
Prior Informed Consent (PIC) Information
Yes
Error loading details for ({"identifier":"FBC414FB-2703-FAA5-D553-890A6F9FACNA@1"})
Confidential information
- Person: Mr Zacharia Jacob | ABSCH-CON-IN-207087-1
Person:
Mr Zacharia Jacob
Director,
Athulya AyurvedicMedical Research Cemtre (AAAMRC)
Jawahar Housing Colony, Cherinchal, Karanthoor, Kunnamangalam
Kozhikode, Kerala
, India
Phone: +91 495 2358016,
Fax:
Email: info@ayurvediccancertherapy.com,
Website:
Confidential information
Mutually Agreed Terms (MAT) Information
Yes
1. The user shall notify the NBA on the grant of IPR within 30 days thereof. 
2. If the user himself commercializes the process/product/innovation, the monetary sharing shall be 0.2% on the annual gross ex-factory sale minus government taxes. 
3. The user needs to inform the NBA about any commercialization made on the IP Rights granted.
4. The user shall submit the half-yearly report to NBA as per the terms and conditions agreed upon.  

Subject-matter or genetic resource(s)

For obtaining IP rights on the invention “Method of preparation of herbal extract for cancer treatment” in India

Biological Resource: Calotropis gigantea

Confidential information
We acknowledge the use of imagery provided by services from NASA’s Global Imagery Browse Services (GIBS), part of NASA’s Earth Observing System Data and Information System (EOSDIS).


Information on the utilization of the genetic resource(s)
  • Commercial
1. If the user assigns/licenses the process/product/innovation to a third party for commercialization, the user shall pay to NBA 3.0% of the fee received (in any form including the license / assignee fee) and 2.0% of the royalty amount received annually from the assignee/licensee. 

2. In case the user assigns or transfer the IPR in whole or in part to any person, whether voluntarily or involuntarily, the user undertakes to attach this agreement as an appendix to the assignment instrument.  

Additional Information
Amendment history
Unique identifier Status Date
ABSCH-IRCC-IN-207615-1
REVOKED OLD VERSION PUBLISHED DELETED
Sujata Arora (sujata@nic.in)
16 Aug 2016 11:50
on 16 Aug 2016 11:50
...less

Quick links

About the ABS Clearing-House About the Nagoya Protocol
Search records Country profiles Submit records

Need help?

Contact us Introduction to the ABSCH Getting started Information sharing obligations How monitoring utilization works Interoperability Offline common formats

ABS Clearing-House